Table 1 Demographic data and clinical characterization of patients enrolled in clinical trial
Group | Patient number | Age range | Sex | Co-morbidities | RT-PCR at baseline | Adverse events | Clinical outcome |
|---|---|---|---|---|---|---|---|
Control group | P1 | 60–69 | 2 | Hypertension | + | NO | Died |
|  | P2 | 60–69 | 2 | Diabetes | + | NO | Discharge |
|  | P3 | 60–69 | 1 | NO | + | NO | Discharge |
|  | P4 | 60–69 | 2 | NO | + | NO | Discharge |
|  | P5 | 50–59 | 2 | Hypertension | + | NO | Discharge |
|  | P6 | 50–59 | 1 | NO | + | NO | Discharge |
|  | P7 | 60–69 | 1 | NO | + | NO | Discharge |
|  | P8 | 50–59 | 2 | NO | + | NO | Discharge |
|  | P9 | 60–69 | 2 | NO | + | NO | Discharge |
|  | P10 | 60–69 | 1 | Hypertension | + | NO | Discharge |
Intervention group | P1 | 50–59 | 1 | Diabetes | + | Mild headache | Died |
|  | P2 | 60–69 | 2 | NO | + | Mild headache | Discharge |
|  | P3 | 50–59 | 1 | NO | + | NO | Discharge |
|  | P4 | 60–69 | 2 | Hypertension | + | NO | Died |
|  | P5 | 70–79 | 2 | NO | + | NO | Discharge |
|  | P6 | 60–69 | 2 | Diabetes | + | NO | Discharge |
|  | P7 | 60–69 | 2 | NO | + | Mild headache | Discharge |
|  | P8 | 60–69 | 1 | Mild anemia | + | NO | Discharge |
|  | P9 | 60–69 | 2 | NO | + | Mild fever | Discharge |
|  | P10 | 50–59 | 2 | NO | + | NO | Discharge |